Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes

Kushal Sejwal1, Mohamed Chami1, Hervé Rémigy2

  • 1Center for Cellular Imaging and NanoAnalytics (C-CINA), Biozentrum, University of Basel, Basel, 4056, Switzerland.

Scientific Reports
|August 19, 2017
PubMed

Insights

Structural insights into Leucine-rich repeat kinase 2 (LRRK2) and LRRK1 dimers were revealed using cryo-electron microscopy. Their similar dimerization mechanisms suggest functional differences arise from other biochemical activities.

Area of Science:

  • Structural Biology
  • Neuroscience
  • Biochemistry

Background:

  • Leucine-rich repeat kinase 2 (LRRK2) is a key protein in Parkinson's disease (PD) pathogenesis.
  • LRRK2 is a promising therapeutic target for PD drug development.
  • LRRK1, LRRK2's homologue, is not associated with PD.

Purpose of the Study:

  • To elucidate the structural basis of Leucine-rich repeat kinase 2 (LRRK2) and Leucine-rich repeat kinase 1 (LRRK1) dimerization.
  • To compare the full-length dimeric structures of LRRK2 and LRRK1.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) and single particle analysis were employed.
  • Differential scanning fluorimetry guided purification buffer optimization for LRRK2.
  • 3D maps were generated to determine protein structures.

Main Results:

  • High-resolution (16 Å for LRRK2, 25 Å for LRRK1) cryo-EM structures of full-length LRRK2 and LRRK1 dimers were obtained.
  • Both proteins exhibit similar two-fold symmetric dimer orientations.
  • Purification in high pH buffer improved LRRK2 cryo-EM image quality.

Conclusions:

  • LRRK2 and LRRK1 share closely related dimerization mechanisms.
  • Functional specificities likely stem from other biochemical activities beyond dimerization.
  • This study provides the first parallel 3D structural insights into LRRK2 and LRRK1 dimers.